You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 21 No. 4, October 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Phenolic Acids in Experimental Uremia

I. Potential Role of Phenolic Acids in the Neurological Manifestations of Uremia

N. Burgess Record, MD; James W. Prichard, MD; Brian B. Gallagher, MD, PhD; David Seligson, MD

Arch Neurol. 1969;21(4):387-394.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MANY ORGANIC acids accumulate in renal failure.1 The role of phenolic acids in the pathogenesis of uremia has been reviewed by Schreiner and Maher2 and others.3-10 Blood phenols are primarily derived from the action of intestinal bacteria on protein derivatives containing aromatic amino acids. They are absorbed from the gut, conjugated in the liver, and excreted principally by the kidneys. Normally total plasma phenols including various amino acids, phenols, and aromatic hydroxy acids do not exceed 0.1 mg/100 ml. Marked elevations of free and conjugated phenols have been detected in uremia and reported to correlate with uremic symptoms, especially those of central nervous system (CNS) depression.3-6

The present study was undertaken to evaluate in vivo the potential contribution of the phenolic compound, 3,4-dihydroxybenzoic acid (3,4-DHBA) (protocatechuic acid) to the pathogenesis of uremia. This compound was selected because it is excreted in considerable amounts (46 . . . [Full Text PDF of this Article]


Author Affiliations

New Haven, Conn

From the sections of neurology and clinical pathology, Yale University School of Medicine, New Haven, Conn.


Footnotes

Submitted for publication April 16, 1969; accepted May 24.

Reprint requests to the Section of Neurology, Yale University School of Medicine, 333 Cedar St, New Haven, Conn 06510 (Dr. Gallagher).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.